{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:21:36Z","timestamp":1783059696453,"version":"3.54.6"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"\n Background<\/jats:title>\n \n Cardiovascular disease (CVD) remains a leading global health threat. The high incidence of coronary artery disease (CAD) is closely associated with atherosclerotic progression, and thrombosis mediated by platelet activation is a key mechanism triggering acute coronary events and contributing to the high mortality of CAD. Omega-3 polyunsaturated fatty acids (\n \u03c9<\/jats:italic>\n -3 PUFA) exert cardiovascular protective effects through anti-inflammatory and antiplatelet aggregation effects. However, their mechanisms underlying the regulation of coronary stenosis severity in CAD via platelet morphological parameters (mean platelet volume, MPV) and their prognostic value remain unclear. This study aims to investigate the association between serum DHA, EPA, and MPV with the onset of CAD, the severity of coronary artery stenosis (Gensini score), and the prognosis of major adverse cardiovascular events (MACE), while validating the mediating effect of MPV.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A total of 183 patients with coronary artery disease (CAD) and 189 controls were included. Baseline data were collected, and levels of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (AA) were measured by ultra-performance liquid chromatography-mass spectrometry. Logistic regression, Spearman correlation analysis, bootstrap mediation analysis, Kaplan\u2013Meier survival analysis, and Cox proportional hazards regression were employed to explore the mechanisms and associations between omega-3 PUFAs, MPV, and CAD onset, coronary artery stenosis severity, and MACE.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Serum DHA levels were significantly lower in the CAD group than in controls (\n P<\/jats:italic>\n \u2009&lt;\u20090.001). Among CAD patients, DHA was significantly negatively correlated with MPV, platelet distribution width (PDW), and platelet large cell ratio (PLCR) (\n r<\/jats:italic>\n \u2009=\u2009\u22120.169, \u22120.156, \u22120.186, all\n P<\/jats:italic>\n \u2009&lt;\u20090.05), while MPV, PDW, and PLCR were weakly positively correlated with Gensini scores (\n r<\/jats:italic>\n \u2009=\u20090.170, 0.158, 0.165, all\n P<\/jats:italic>\n \u2009&lt;\u20090.05). Bootstrap mediation analysis confirmed that MPV showed a statistically significant mediating effect in the association between DHA and Gensini score, consistent with a mediation model (\n P<\/jats:italic>\n \u2009=\u20090.034). Prognostic analyses demonstrated that DHA was an independent protective factor for MACE (HR\u2009=\u20090.83, 95% CI: 0.74\u20130.93,\n P<\/jats:italic>\n \u2009=\u20090.002),MPV was an independent risk factor for MACE (HR\u2009=\u20091.22, 95% CI: 1.00\u20131.49,\n P<\/jats:italic>\n \u2009=\u20090.046), and the combination of \u201chigh DHA (\u22651.4127\u2005\u03bcmol\/L)\u2009+\u2009low MPV (\u226410.4\u2005fL)\u201d significantly reduced the risk of MACE (Log-rank test,\n P<\/jats:italic>\n \u2009=\u20090.0011).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n DHA is associated with coronary stenosis severity, and this association is statistically consistent with partial mediation by MPV. The combined assessment of DHA and MPV optimizes risk stratification in CAD patients, providing quantitative evidence for personalized nutritional interventions with significant clinical translational value.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1809653","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:38:25Z","timestamp":1783057105000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The mediating effect of DHA-mediated MPV improvement on coronary artery stenosis and its prognostic value"],"prefix":"10.3389","volume":"13","author":[{"given":"Wenli","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Foshan Second People's Hospital, The Affiliated Foshan Hospital of Guangdong Pharmaceutical University","place":["Foshan, China"]},{"name":"School of First Clinical Medicine, Guangdong Medical University","place":["Zhanjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changguo","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Foshan Second People's Hospital, The Affiliated Foshan Hospital of Guangdong Pharmaceutical University","place":["Foshan, China"]},{"name":"School of First Clinical Medicine, Guangdong Medical University","place":["Zhanjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiu","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Foshan Second People's Hospital, The Affiliated Foshan Hospital of Guangdong Pharmaceutical University","place":["Foshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Foshan Second People's Hospital, The Affiliated Foshan Hospital of Guangdong Pharmaceutical University","place":["Foshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangxiong","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Foshan Second People's Hospital, The Affiliated Foshan Hospital of Guangdong Pharmaceutical University","place":["Foshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Foshan Second People's Hospital, The Affiliated Foshan Hospital of Guangdong Pharmaceutical University","place":["Foshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohua","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Foshan Second People's Hospital, The Affiliated Foshan Hospital of Guangdong Pharmaceutical University","place":["Foshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangguang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Eighth Affiliated Hospital of Southern Medical University","place":["Foshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Eighth Affiliated Hospital of Southern Medical University","place":["Foshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Foshan Second People's Hospital, The Affiliated Foshan Hospital of Guangdong Pharmaceutical University","place":["Foshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990\u20132022","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood-2016-03-703157","article-title":"Platelet WDR1 suppresses platelet activity and is associated with cardiovascular disease","volume":"128","author":"Montenont","year":"2016","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nrcardio.2012.131","article-title":"The causal role of megakaryocyte\u2013platelet hyperactivity in acute coronary syndromes","volume":"9","author":"Martin","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.5935\/abc.20190058","article-title":"Clinical significance of platelet volume and other platelet parameters in acute myocardial infarction and stable coronary artery disease","volume":"112","author":"Ding","year":"2019","journal-title":"Arq Bras Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2018.08.048","article-title":"Mean platelet volume and long-term cardiovascular outcomes in patients with stable coronary artery disease","volume":"277","author":"Wada","year":"2018","journal-title":"Atherosclerosis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/00033197211070908","article-title":"The prognostic utility of mean platelet volume in patients with acute coronary syndrome: a systematic review with meta-analyses","volume":"73","author":"Galimzhanov","year":"2022","journal-title":"Angiology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.advnut.2023.03.014","article-title":"The potential cardiometabolic effects of long-chain \u03c9-3 polyunsaturated fatty acids: recent updates and controversies","volume":"14","author":"Bae","year":"2023","journal-title":"Adv Nutr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"767535","DOI":"10.3389\/fnut.2021.767535","article-title":"Omega-3 fatty acids improve functionality of high-density lipoprotein in individuals with high cardiovascular risk: a randomized, parallel, controlled and double-blind clinical trial","volume":"8","author":"Cartolano","year":"2022","journal-title":"Front Nutr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/ijms21041362","article-title":"Marine Omega-3 (N-3) fatty acids for cardiovascular health: an update for 2020","volume":"21","author":"Innes","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.3390\/nu13072421","article-title":"Beneficial outcomes of Omega-6 and Omega-3 polyunsaturated fatty acids on human health: an update for 2021","volume":"13","author":"Djuricic","year":"2021","journal-title":"Nutrients"},{"key":"B12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.123.065520","article-title":"Randomized trial for evaluation in secondary prevention efficacy of combination therapy-statin and eicosapentaenoic acid (RESPECT-EPA)","volume":"150","author":"Miyauchi","year":"2024","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"106700","DOI":"10.1016\/j.prostaglandins.2022.106700","article-title":"DHA, RvD1, RvD5, and MaR1 reduce human coronary arteries contractions induced by PGE2","volume":"165","author":"Bouhadoun","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B14","doi-asserted-by":"publisher","first-page":"20406223221081616","DOI":"10.1177\/20406223221081616","article-title":"Long-chain omega-3 polyunsaturated fatty acids and the risk of heart failure","volume":"13","author":"Zheng","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26599\/1671-5411.2025.01.008","article-title":"Chinese Guidelines for the prevention and treatment of hypertension (2024 revision)","volume":"22","author":"Wang","year":"2025","journal-title":"J Geriatr Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc26-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1190934","DOI":"10.3389\/fphar.2023.1190934","article-title":"2023 Chinese guideline for lipid management","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e82130","DOI":"10.7759\/cureus.82130","article-title":"Evaluation of platelet indices in coronary artery disease: an institutional study","volume":"17","author":"Kannappalli","year":"2025","journal-title":"Cureus"},{"key":"B19","doi-asserted-by":"publisher","first-page":"904250","DOI":"10.3389\/fcvm.2022.904250","article-title":"Effects of \u03c9-3 polyunsaturated fatty acids on coronary atherosclerosis and inflammation: a systematic review and meta-analysis","volume":"9","author":"Gao","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/eurheartj\/ehr362","article-title":"Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?","volume":"33","author":"Kromhout","year":"2012","journal-title":"Eur Heart J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2012.10.056","article-title":"Influence of omega-3 polyunsaturated fatty acid-supplementation on platelet aggregation in humans: a meta-analysis of randomized controlled trials","volume":"226","author":"Gao","year":"2013","journal-title":"Atherosclerosis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1160\/TH11-03-0169","article-title":"Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure","volume":"106","author":"Moertl","year":"2011","journal-title":"Thromb Haemost"},{"key":"B23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0021-9150(02)00307-6","article-title":"Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients","volume":"166","author":"Woodman","year":"2003","journal-title":"Atherosclerosis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/jth.15184","article-title":"DHA 12-LOX-derived Oxylipins regulate platelet activation and thrombus formation through a PKA-dependent signaling pathway","volume":"19","author":"Yamaguchi","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clnu.2025.03.020","article-title":"Circulating polyunsaturated fatty acids percentages and coronary artery disease incidence and mortality: observational and Mendelian randomization analyses","volume":"48","author":"Liu","year":"2025","journal-title":"Clin Nutr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41467-021-22370-2","article-title":"Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies","volume":"12","author":"Harris","year":"2021","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e017401","DOI":"10.1161\/JAHA.120.017401","article-title":"Plasma Omega-3 fatty acids and the risk of cardiovascular events in patients after an acute coronary syndrome in MERLIN-TIMI 36","volume":"10","author":"Zelniker","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B28","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s11239-025-03121-2","article-title":"Indications of platelet indices in coronary artery disease (CAD): more insights into their diagnostic and prognostic importance","volume":"58","author":"Hosseini","year":"2025","journal-title":"J Thromb Thrombolysis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e14295","DOI":"10.1111\/eci.14295","article-title":"The prognostic value of mean platelet volume in patients with coronary artery disease: an updated systematic review with meta-analyses","volume":"54","author":"Galimzhanov","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1055\/s-0041-1735326","article-title":"Association of mean platelet volume with risk factors and functional outcome in acute ischemic stroke","volume":"12","author":"Ot","year":"2021","journal-title":"J Neurosci Rural Pract"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1809653\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:38:26Z","timestamp":1783057106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1809653\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":30,"alternative-id":["10.3389\/fcvm.2026.1809653"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1809653","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"article-number":"1809653"}}